LENSAR Announces Presentations at American Academy of Ophthalmology Highlighting the Advantages of Streamline IV in Both Cata...
November 11 2020 - 4:01PM
Business Wire
LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a
global medical technology company focused on femtosecond laser
surgical solutions for the treatment of cataracts, today announced
that three posters and a paper have been accepted for virtual
presentations at the Annual Meeting of the American Academy of
Ophthalmology (AAO) being held November 13-15, 2020.
Paper Presentation
Paper title: Refractive Outcomes of a Light-Adjustable
IOL in Cataract Patients With a History of RK Presenter:
James D Lehmann, MD, Focal Point Vision, San Antonio, TX
Date: The poster presentation will be available on the AAO
meeting portal starting November 11, 2020
Poster Presentations
Presentation title: Outcome of Arcuate Keratotomy Using
Iris Registration–Guided Femtosecond Laser for the Management of
Astigmatism During Cataract Surgery Presenter: Seong-Jun
Lee, MD, PHD, Medical Director, Nuri Eye Clinic, Daejeon, Korea
Date: The poster presentation will be available on the AAO
meeting portal starting November 11, 2020
Presentation title: Outcome of Toric IOLs Aligned With
Iris Registration-Guided, FsL-Assisted Capsular Marks for the
Management of Astigmatism During Cataract Surgery Presenter:
Seong-Jun Lee, MD, PHD, Medical Director, Nuri Eye Clinic, Daejeon,
Korea Date: The poster presentation will be available on the
AAO meeting portal starting November 11, 2020
Presentation title: Femtosecond Laser-Assisted
Capsulotomy With Capsular Marks for Guiding Toric IOL Alignment
During Cataract Surgery Presenter: Vasilios F Diakonis, MD,
PHD, The Eye Institute of West Florida, Largo, FL Date: The
poster presentation will be available on the AAO meeting portal
starting November 11, 2020
About LENSAR
LENSAR is a commercial-stage medical device company focused on
designing, developing and marketing an advanced femtosecond laser
system for the treatment of cataracts and the management of
pre-existing or surgically induced corneal astigmatism. Its LENSAR
Laser System incorporates a range of proprietary technologies
designed to assist the surgeon in obtaining better visual outcomes,
efficiency and reproducibility by providing advanced imaging,
simplified procedure planning, efficient design and precision.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201111005826/en/
Thomas R. Staab, II, CFO ir.contact@lensar.com
Lee Roth / Cameron Radinovic Burns McClellan for LENSAR
lroth@burnsmc.com / cradinovic@burnsmc.com
LENSAR (NASDAQ:LNSR)
Historical Stock Chart
From Aug 2024 to Sep 2024
LENSAR (NASDAQ:LNSR)
Historical Stock Chart
From Sep 2023 to Sep 2024